Pyxis Oncology
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Pyxis Oncology generated cash of -$70,709,000, which is more than the previous year. Cash used in financing activities reached the amount of $5,929,000 last year. Net change in cash is therefore -$169,629,000.
Cash Flow
| 2019 | -2.23M | 0 | 21.95M |
|---|---|---|---|
| 2020 | -10.08M | -1.48M | 35K |
| 2021 | -35.32M | -590K | 304.04M |
| 2022 | -89.33M | -6.39M | 183K |
| 2023 | -70.70M | -104.84M | 5.92M |
PYXS Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 180.76M | 276.31M | 8.18M | 19.72M | 4K |
Operating activities | |||||
Net income | -73.79M | -120.71M | -75.97M | -12.82M | -2.77M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 1.92M | 709K | 647K | 469K | 0 |
Stock-based compensation expense | 16.94M | 15.76M | 6.44M | 44K | 28K |
| Deferred income tax benefit | 16.94M | 15.76M | 6.44M | 44K | 28K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -3.50M | -8.32M | 4.64M | 558K | 292K |
Cash generated by operating activities | -70.70M | -89.33M | -35.32M | -10.08M | -2.23M |
Investing activities | |||||
Purchases Of Investments | -196.83M | 0 | -50K | 0 | 0 |
Investments In Property Plant And Equipment | -6.72M | -6.39M | -540K | -1.48M | 0 |
Acquisitions Net | 6.66M | 0 | -50K | 0 | 0 |
Cash generated by investing activities | -104.84M | -6.39M | -590K | -1.48M | 0 |
Financing activities | |||||
Common Stock Issued | 6.12M | 183K | 152.29M | 35K | 13K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 5.92M | 183K | 304.04M | 35K | 21.95M |
Net Change In Cash | -169.62M | -95.55M | 268.12M | -11.53M | 19.71M |
Cash at end of period | 11.13M | 180.76M | 276.31M | 8.18M | 19.72M |
| Data source | Data source | Data source |